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Impairments in mitochondria, oxidative regulation, and calcium homeostasis have
been well documented in numerous Amyotrophic Lateral Sclerosis (ALS) experimental
models, especially in the superoxide dismutase 1 glycine 93 to alanine (SOD1 G93A)
transgenic mouse. However, the timing of these deficiencies has been debatable. In
a systematic review of 45 articles, we examine experimental measurements of cellular
respiration, mitochondrial mechanisms, oxidative markers, and calcium regulation. We
evaluate the quantitative magnitude and statistical temporal trend of these aggregated
assessments in high transgene copy SOD1 G93A mice compared to wild type mice.
Analysis of overall trends reveals cellular respiration, intracellular adenosine triphosphate,
and corresponding mitochondrial elements (Cox, cytochrome c, complex I, enzyme
activity) are depressed for the entire lifespan of the SOD1 G93A mouse. Oxidant markers
(H2O2, 8OH2′dG, MDA) are initially similar to wild type but are double that of wild type
by the time of symptom onset despite early post-natal elevation of protective heat shock
proteins. All aspects of calcium regulation show early disturbances, although a notable
and likely compensatory convergence to near wild type levels appears to occur between
40 and 80 days (pre-onset), followed by a post-onset elevation in intracellular calcium.
The identified temporal trends and compensatory fluctuations provide evidence that
the “cause” of ALS may lay within failed homeostatic regulation, itself, rather than any
one particular perturbing event or cellular mechanism. We discuss the vulnerabilities of
motoneurons to regulatory instability and possible hypotheses regarding failed regulation
and its potential treatment in ALS.
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Introduction
Amyotrophic Lateral Sclerosis (ALS) is a late-onset neurodegenerative disease consisting of
progressive muscle atrophy, muscle paralysis, dysarthria, dysphagia, and dyspnea. While there
has been much research conducted on the disease, the precise causes and eﬀective treatments
have remained elusive. Transgenic mice, and namely the superoxide dismutase 1 glycine 93 to
alanine mutation (SOD1 G93A), have served as the predominant means by which to investigate
the underlying cellular pathophysiology (Pfohl et al., 2015). Amultitude of categorical disturbances
have been identiﬁed, which are described in detail in a recent informatics-based systematic review
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of the SOD1 G93A ﬁeld (Kim et al., 2015): apoptosis, including
changes in pro- and anti-apoptotic signals; energetics, including
mitochondrial dysfunction, adenosine triphosphate (ATP)
depletion, and calcium homeostasis; excitability, including
hypoexcitability, hyperexcitability, and excitotoxicity; genetic
transcription, including damage to mRNA and DNA;
inﬂammation, due to reactive microglia and astrocytes;
oxidative stress, from the production of free radicals; proteomics,
including the build-up of mutant protein aggregates and reduced
autophagy or proteasome function; and systemic function, which
also includes potential non-neuromuscular contributors.
This Frontiers Research Topic and present study focuses on a
unique and highly inter-related triad of the ALS pathophysiology:
the role of mitochondria, oxidative stress, and altered calcium
homeostasis. Most of the previous experimental work has
focused on identifying the presence of impairments in this
triad using a wide variety of speciﬁc methods and measures,
such as recording of the mitochondrial potential, evaluation of
intracellular ATP concentration, electrophysiological assessment
of calcium entry, and measurement of intracellular free radicals.
While the presence of deﬁciencies in mitochondria, oxidative
regulation, and calcium homeostasis has been well established,
their timing, as a function of ALS disease initiation and
progression, is less understood. The goal of this work is
to evaluate their overall temporal trends, pre-natal through
death, in the SOD1 G93A transgenic ALS mouse model. In
this systematic review of 45 articles, we aggregate in vitro,
embryonic, and in vivo experimental measurements of cellular
respiration, mitochondrial mechanisms, oxidative and anti-
oxidative markers, and intracellular calcium in both SOD1 G93A
transgenic ALS mice and in wild type control mice. We evaluate
the magnitude and statistical trend of these assessments in SOD1
G93A mice compared to wild type mice and examine changes
over the course of the SOD1 G93A mouse life span.
Materials and Methods
The general method includes: (1) identifying and recapturing
published experimental data for SOD1 G93A transgenic mouse
and wild type control mouse assessments of mitochondrial
function, oxidative stress, and calcium homeostasis;
(2) Normalizing recaptured data to temporally compare the
assessed measures; (3) Performing a Gaussian average to
temporally interpolate the values and develop a visual trend line
for each measure and category of measures.
Inclusion and Exclusion Criteria
Potential articles were identiﬁed under the PubMed search
criteria of (G93A OR transgenic mouse) AND (ALS OR
“Amyotrophic Lateral Sclerosis”). Initial exclusion criteria
consisted of: non-English language articles; articles for which full-
text pdf downloads were unavailable (see Data Recapture); and
articles labeled as literature reviews.
Keyword searches of recaptured ﬁgure captions and within
ﬁgure text were performed to ﬁnd relevant articles from
the initial literature pool (see Data Recapture) using the
following terms: calcium and its permutations, including
Ca2+, Ca, etc.; mitochondria and its permutations (mito∗);
oxidative stress and its permutations (oxid∗), reactive oxygen
species (ROS), free radicals, hydrogen peroxide (H2O2),
nitric oxide (NO), malondialdehyde (MDA), 8-hydroxy-2′-
deoxyguanosine (8OH2′dG), heat shock proteins (HSPs).
Study-speciﬁc inclusion criteria required the use of both
non-treated SOD1 G93A and wild type transgenic mice for a
given quantitative experimental measurement. “Non-treated”
consisted of controlled experimental assessments of the measured
parameter(s) without the application of chemicals or processes
meant to intentionally attempt to modify the assessed measures
or related physiology.
Data Recapture
Articles were either downloaded using PubMed Central or
from e-journal subscriptions available from the libraries of
Georgia Institute of Technology and Emory University. Data was
recaptured from the following article locations (Kim et al., 2015),
referred to as entities: article title; abstract; ﬁgure captions; within
ﬁgure text (x–y axis labels, bar graph categorical labels, legends,
etc.); and data series and response values (e.g., quantiﬁable
ﬁgure/table data). Data was scraped from the full-text pdf article.
Every data point was reviewed by an independent quality control
team to insure complete accuracy.
Categorical Definitions
Given that each study utilizes its own speciﬁc measures,
aggregation is a requirement in order to obtain a meaningful
visualization of categorical trends and meta-analysis results.
Experimental measures were aggregated into four main
categories: calcium regulation, cellular respiration, mitochondrial
mechanisms, and oxidative regulation. Sub-categories of
measures are further deﬁned within each category as discussed
below.
Calcium Regulation
The calcium regulation category includes experimental
assessments of intracellular calcium dynamics, including calcium
entry, calcium sinks, free calcium concentration, and calcium
sensitivity. Calcium entry encompassed electrophysiological
measurements of extracellular calcium entering through the
membrane of motoneuron cells (e.g., Ca2+ persistent inward
current, Ca2+ amplitude, Cell Voltage, Cellular Calcium,
etc.). Calcium sensitivity included measures of mitochondrial
membrane sensitivity to a discretely measured calcium challenge.
Calcium sink values encompassed measures of calcium buﬀering
or calcium capacity. Calcium concentration encompassed
general cytosolic free calcium levels.
Cellular Respiration
The cellular respiration category includes measures of general
respiration rate as well as intracellular concentrations of
ATP and adenosine diphosphate (ADP). Measures of the
general respiration rate include production of heme, oxygen
consumption, or respiration control ratio.
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Respiration Mechanisms
Respiration mechanisms included experimental assessment of
complex I activity, COX activity, Cytochrome C levels, and
general mitochondrial enzyme activity (including Complex III,
IV, V). These parameters are involved the electron transport
chain (ETC), which leads to the production of ATP.
Oxidative Regulation
Experimentally assessed contributors to oxidative stress include
hydrogen peroxide (H2O2) production and the oxidant markers
MDA and 8-hydroxy-2′-deoxyguanosine (8OH2′dG). The
concentration of HSP was also incorporated in the oxidative
regulation category given their neuroprotective eﬀects and
potential impact on the slowing of oxidant-induced symptoms.
Speciﬁc HSPs included HSP 25, 27, and 70.
Tissue Sources
In vivo tissues primarily consisted of SOD1 G93A mouse brain
or spinal cord cells; in fact, 35 articles identiﬁed at least one of
these two regions as a source. Some articles utilized homogenized
tissue or multiple tissue sources (Leclerc et al., 2001; Damiano
et al., 2006; Johnson et al., 2011; Miana-Mena et al., 2011), which
included spinal cord or brain tissue with other systemic tissues,
such as blood, liver, soleus, diaphragm, and liver. Tissues used for
in vitro assessment were more varied. Cell lines mostly included
standard SOD1 G93A transfected mice cells. However, other
G93A-transfected sources included SH-SY5Y cells (Carri et al.,
1997; Goos et al., 2007; Pesaresi et al., 2011), NSC-34 cells (Liu
et al., 2002; Ferri et al., 2008; Mali and Zisapel, 2009; Crippa
et al., 2010), yeast (Gunther et al., 2004; Kloppel et al., 2010), and
bacteria (Singh et al., 1998).
Analysis
The ratio of SOD1 G93A to wild type (e.g., SOD1 G93A/wild
type) is used to normalize each assessed measure. Each study was
normalized to its own published wild type data. For each included
measure or category of measures, the ratio of SOD1G93A to wild
type is plotted versus time. Data from each article is given equal
weight. For ease of visualization, all in vitro cell line experimental
data is plotted as −20 days and embryonic experimental data is
plotted as −5 days; in vivo data is plotted at its corresponding
post-natal day of experimental assessment. A standard Gaussian
average was performed to interpolate values in-between the raw
experimental data points and to produce trend lines indicative of
the general aggregate behavior of each experimentally measured
parameter.
Results
In total, 262 data points from 45 unique papers were collected
and normalized for inclusion in this meta-analysis. Table 1 shows
TABLE 1 | Categorization, distribution, and sources of included experimental data.
Papers Values Sources
Calcium regulation
Entry 2 12 Johnson et al. (2011), Quinlan et al. (2011)
Sensitivity 2 11 Pieri et al. (2003), Damiano et al. (2006)
Sink 6 14 Pieri et al. (2003), Damiano et al. (2006), Igoudjil et al. (2011), Milanese et al. (2011), Pesaresi et al.
(2011), Tradewell et al. (2011)
Concentration 9 26 Carri et al. (1997), Kruman et al. (1999), Beers et al. (2001), Goos et al. (2007), Guatteo et al. (2007),
Milanese et al. (2011), Nutini et al. (2011), Panov et al. (2011), Tradewell et al. (2011)
Mitochondrial mechanisms
Complex I 1 3 Loizzo et al. (2010)
Enzyme activity 5 49 Leclerc et al. (2001), Jung et al. (2002), Mattiazzi et al. (2002), Wendt et al. (2002), Gunther et al.
(2004)
COX 1 4 Kirkinezos et al. (2005)
Cytochrome C 5 11 Guégan et al. (2001), Jung et al. (2002), Liu et al. (2002), Kirkinezos et al. (2005), Damiano et al.
(2006)
Cellular respiration
Adenosine triphosphate (ATP) 4 21 Browne et al. (2006), Ferri et al. (2008), Mali and Zisapel (2009), Peixoto et al. (2013)
Adenosine diphosphate (ADP) 2 18 Leclerc et al. (2001), Browne et al. (2006)
Respiration rate 7 20 Gunther et al. (2004), Damiano et al. (2006), Cassina et al. (2008), Igoudjil et al. (2011), Panov et al.
(2011), Miquel et al. (2012), Zhao et al. (2012)
Oxidative Regulation
8-hydroxy-2′-deoxyguanosine, 8OH2′dG 1 4 Fang et al. (2010)
Hydrogen peroxide, H2O2 5 7 Singh et al. (1998), Liu et al. (1999, 2009), Takamiya et al. (2003), Kloppel et al. (2010)
Malondialdehyde (MDA), C3H4O2 5 36 Hall et al. (1998), Liu et al. (1999), Fang et al. (2010), Miana-Mena et al. (2011), Seo et al. (2011)
Heat shock proteins (HSP) 5 26 Vleminckx et al. (2002), Batulan et al. (2003), Maatkamp et al. (2004), Jaarsma et al. (2008), Crippa
et al. (2010)
There are four major categories of measures: intracellular calcium, mitochondrial mechanisms, cellular respiration, and oxidative regulation). Sub-categories of measures,
as defined in the Methods, are listed under each category along with the number of included unique articles and extracted data points. Each data point represents a
paired SOD1 G93A and wild type mouse assessment at a discrete time point.
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the experimental data point and article distribution to each of the
deﬁned categories and subcategories of measures. The category,
mitochondrial mechanisms, which contains measurements of
constituents necessary for cellular respiration, includes 67 values
from 10 unique articles. Cellular respiration, which includes
the assessed respiration rate and intracellular concentrations
of ATP and ADP, includes 59 values from 12 unique articles.
The oxidative stress category, which includes oxidative markers
and anti-oxidative HSPs, has a total of 73 values from 14
unique articles. Intracellular calcium, which contains measures
examining intracellular calcium homeostasis, contains 63 data
points from 15 unique articles.
Cellular Respiration is Depressed for Entire
Lifespan
Among the most interesting trends found in this meta-analysis
study is that ATP production, along with general respiration
rates, were found to be depressed for the entire lifespan of
the SOD1 G93A mouse (Figure 1). While it has been well
documented that respiration rates are lowered in ALS (Kawamata
and Manfredi, 2010; Cozzolino and Carri, 2012; Peixoto et al.,
2013) even well before physical pathologies develop (Browne
et al., 2006), this meta-analysis supports the assertion that this
phenomenon is a trend that, at least in the high-copy SOD1G93A
transgenic mouse model, is present since birth. That is, the SOD1
G93A mice have notable depression of cellular energetics well
before symptom onset, and this depression remains throughout
the course of disease progression.
Figure 1 illustrates the ratio of transgenic mouse to wild
type mouse experimentally measured levels of intracellular ATP,
ADP, and respiration rate. All of the in vitro cellular data
(plotted as −20 days in Figure 1) collected for intracellular
ATP concentration and respiration rate fall well below their wild
type counterparts. Examining the mathematical mean of in vitro
measures of ATP and respiration rate reveal that SOD1 G93A
levels are approximately 70% of those seen in wild type, which
is equivalent to a 30% reduction.
Post-natal in vivo assessment of intracellular ATP and
respiration rate in SOD1 G93A mice also shows substantial
depression compared to wild type mice. While ATP and
respiration rate is depressed throughout the life span of the
SOD1 G93A mouse, there appears to be small ﬂuctuations
throughout the disease course. However, more data is necessary
to determine whether these small ﬂuctuations are statistically or
mechanistically meaningful. ATP is at its lowest at the disease
end point, where ATP levels approach only 30% of wild type
(Figure 1). Interestingly, the temporal trend of ADP is slightly
diﬀerent than ATP and respiration rate. For most of the disease
course, ADP is depressed in a similar manner to ATP and
respiration. However, ADP levels in SOD1 G93A mice show an
interesting rise above wild type control mice that occurs near
the disease end point. This near-death rise in ADP could be
FIGURE 1 | Cellular respiration is depressed for the lifespan of the
SOD1 G93A transgenic mouse model. The ratio of SOD1 G93A to wild
type (SOD1 G93A/wild type) is plotted over time for experimental measures
of adenosine triphosphate (ATP), adenosine diphosphate (ADP), and general
respiration rate. Solid lines illustrate predicted trend lines. For visualization
purposes, in vitro data is plotted at −20 days and in vivo time points are
plotted at their corresponding post-natal day of assessment, 0–150 days.
A gray dotted line is provided to show the expected wild type or
homeostatic value. Trend lines are generated based on a Gaussian average
of the normalized data points.
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attributed to the cells’ inability to convert ADP to ATP, which
would leaveADP in excess. In fact, this same trend in the lowering
of the ATP/ADP ratio is seen in clinical patients (Ghiasi et al.,
2012).
Depression of Mitochondrial Mechanisms
Additionally, measures of mitochondrial mechanisms and signals
necessary for respiration and ATP production are similarly
depressed throughout the course of the disease. Figure 2A
illustrates the temporal trends of four diﬀerent mitochondrial
mechanism measurements and signals necessary for cellular
respiration: complex I, COX, general enzyme activity, and
cytochrome C. In vitro measures were only obtainable for
enzyme activity, which shows a depression similar to that seen
in ATP levels. Post-natal in vivo assessment of SOD1 G93A
mice reveals that all four of the mitochondrial mechanism
measurements are generally depressed compared to wild type.
The in vivo depression is present at birth and throughout the
entire disease duration. Although the mitochondrial mechanism
experimental measures remain below wild type, the Gaussian
average trend lines identify a potential small bump in
mitochondrial mechanism activity near disease onset (around
80 days), which could represent a regulatory compensation
mechanism; a larger sample size is necessary to determine if this
small bump has possible statistical or mechanistic implications
in disease progression. Finally, when the mitochondria’s ability
to produce ATP is impaired, there is a compensatory increase in
mitochondrial enzyme complexes, especially Complex II, III, IV
(Nalbandian et al., 2015). This upward trend in mitochondrial
enzymes is seen Figure 2A near post-onset and the disease end
point.
Elevation of Oxidants Near Onset
Oxidant levels have been documented as being elevated
throughout diﬀerent stages of ALS (Liu et al., 2002; Mattiazzi
et al., 2002; Martin et al., 2007), including pre-onset (around
40 days), onset (80 days), and especially end-stage (120+ days).
In Figure 2B we plot the temporal trends of three commonly
measured oxidants in SOD1 G93A mice (8OH2′dG, MDA, and
H2O2). The data presented in Figure 2B reveals that SOD1
G93A intracellular oxidant levels are initially similar to slightly
above wild type at birth. However, by pre-onset, levels are
mildly elevated, and at onset and end point, oxidant levels are
substantially increased compared to wild type. In vitro assessment
of oxidants does not reveal as pronounced of elevation as the
in vivo assessments. In vivo assessment of oxidants reveals a
1.5 factor increase in oxidants compared to wild type around
symptom onset (80 days). In vivo assessment near the SOD1
G93A disease end point (120+ days) reveals oxidant levels that
are a factor of 2–8 times greater than seen in wild type control
mice.
Heat shock proteins, which have an anti-oxidative eﬀect, are
also plotted in Figure 2B. HSPs in SOD1 G93A mice were found
to initially be substantially greater than wild type levels, but
they exhibited a ﬂuctuating decline as the disease progressed.
However, there appears to be a recurrent delayed rise in HSP
as the disease enters the symptomatic stage (around 80 days).
FIGURE 2 | Temporal trends of mitochondrial mechanisms, oxidant
regulation, and calcium regulation in the SOD1 G93A transgenic
mouse model. The ratio of SOD1 G93A to wild type (SOD1 G93A/wild type)
is plotted over time for each experimental measure. For visualization
purposes, in vitro data is plotted at −20 days, embryonic data is plotted at
−5 days, and in vivo time points are plotted at their corresponding post-natal
day of assessment, 0–150 days. A gray dotted line is provided to show the
expected wild type or homeostatic value. Trend lines are generated based on
a Gaussian average of the normalized data points. (A) Mitochondrial
mechanisms (Complex I, COX, enzyme activity, and cytochrome c).
(B) Oxidant markers (8OH2′dG, MDA, H2O2) and protective heat shock
proteins (HSPs). (C) Calcium regulation (entry, sensitivity, sink, and cytosolic
concentration).
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FIGURE 3 | Inter-relationships in the mitochondrial
mechanism-oxidative regulation-calcium regulation triad center
around cellular respiration. Each square is colored based on whether
the assessed category is, on average, higher (green), or lower (red) in
SOD1 G93A mice compared to wild type as determined by the overall
trend line directionality from 0 to 150 days. The color of the arrow
indicates the sign of the relationship, and the size indicates the relative
magnitude.
This ﬂuctuation has been previously described. It is hypothesized
that HSP levels are insuﬃcient to quell the oxidant rise. Thus,
decreased HSP levels actually precede motor neuron loss in ALS
(Maatkamp et al., 2004).
Fluctuations of Intracellular Calcium
Calcium homeostasis is critical for both functional neural
excitability and normal cellular signaling. There are four
main experimental types of calcium regulatory measurements:
calcium entry (incoming calcium through ion channels), calcium
sensitivity (measurement of the cell’s rate of response to calcium),
calcium sink (binding and storage of intracellular calcium,
including buﬀers, transporters, and intracellular stores), and the
actual calcium concentration (free intracellular concentration).
Each of these measures contributes to the balance or homeostasis
of intracellular calcium.
In vitro data examining free intracellular calcium
concentration is conﬂicting, with about half of the data points
showing elevated calcium and half showing lower intracellular
calcium compared to wild type (points plotted at −20 days in
Figure 2C). These apparent conﬂicts in in vitro intracellular
calcium concentration could possibly be explained by the usage
of diﬀerent tissue types for in vitro assessment (see Tissue
Sources). Measurements of in vitro calcium sinks are depressed
compared to wild type, ranging from 60 to 80% of that seen
in wild type mice, and calcium sensitivity is about 30% of wild
type. Post-natal in vivo assessment of intracellular calcium and
calcium entry at birth reveals levels that are substantially above
wild type. However, free calcium and calcium entry appears to
dip to near-normal levels during pre-onset. There is limited data
for SOD1 G93A mice calcium entry and concentration from
onset through end point, but available data revels that calcium
appears to rise sharply after onset, resulting in a disease end point
intracellular calcium concentration that is a factor 1.5 greater
than wild type. In vivo assessment of calcium sinks and calcium
sensitivity in SOD1 G93A mice show depressed levels compared
to wild type from birth through the disease end point. Intuitively,
the point at which the calcium sink trend line is highest coincides
with the time points when calcium concentration, or free-ﬂoating
calcium, is lowest.
Discussion
The results of our systematic review and meta-analysis of 45
articles shed new light on the temporal trends of cellular
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respiration, oxidative markers, mitochondrial mechanisms, and
calcium regulation in the SOD1 G93A transgenic ALS mouse
model. By aggregating data, we show that cellular respiration
and corresponding mitochondrial mechanism are impaired for
the entire lifespan of the SOD1 G93A mouse. Oxidant markers
are initially similar to wild type but are more than double
that of wild type by the time of symptom onset despite early
post-natal elevation of protective HSPs. All aspects of calcium
regulation show early disturbances, although a notable and
likely compensatory convergence to near wild type levels occurs
between 40 and 80 days, which is followed by a divergence after
symptom onset.
This systematic review clearly shows that SOD1 G93A mice
exhibit a long-term metabolic deﬁcit, however, these symptoms
are also present in other ALS mouse models. Dupuis et al. (2004)
performed metabolic experiments on both G93A and G86R mice
to demonstrate the similarities in mitochondrial function. G37R
mice also show signiﬁcant reduction in ATP production (Coussee
et al., 2011). Finally, substantial metabolic disturbances have also
been documented in non-SOD transgenic mice, including mice




There are multiple feedback loops between the triad of cellular
respiration, calcium regulation, and oxidative regulation. The
inter-relationships between the categories and sub-categories of
measurements examined in this meta-analysis are illustrated in
Figure 3. Red boxes indicate parameters, which are lower in
SOD1G93Amice compared to wild type, and green box indicates
parameters, which are higher in SOD1 G93A mice compared to
wild type. Similarly, the color of the arrows indicates either a
positive relationship (green) or a negative relationship (red), and
their size indicates the relative strength of the relationship. The
biology of these interactions is summarized below.
Mitochondria have a highly interactive dynamic with the
endoplasmic reticulum (ER), the main intracellular calcium
storehouse. Mitochondria take up calcium via the calcium-
sensitive mitochondrial uniporter. However, sustained free
cytosolic calcium inactivates the uniporter, preventing further
calcium uptake (Moreau et al., 2006). Accumulated calcium in
the mitochondria can then be released back into the cytosol
via the sodium–calcium and hydrogen–calcium exchangers
(Fuchs et al., 2013). Once intramitochondrial calcium rises
above a certain level, the mitochondrial transition pore opens,
initiating apoptotic or necrotic signaling cascades (Leung and
Halestrap, 2008). Calcium originating from the activation of
AMPA receptors and/or pathologically increased membrane
permeability is thought to result in this shift of calcium from the
ER to the mitochondria. Ryanodine receptors on the surface of
the ER further amplify calcium-mediated calcium release from
the ER, which in turn, could further exacerbate AMPA activation
(Berridge, 2002). A second receptor that exacerbates calcium
release from the ER is the calcium-activated IP3R.
Collectively, intracellular release of calcium from the ER,
mitochondria, and other intracellular stores could explain the
increase in intracellular cytosolic calcium concentration seen
near onset (∼100 days), which is mirrored by a paradoxical
decrease in extracellular calcium entry (see Figure 2C). Another
contributor for this apparent paradox could be a decrease
in expression of calcium binders like calbindin D28K and
parvalbumin (Celio, 1990), which have been proposed to
result in increased cytosolic calcium in ALS mice (Appel
et al., 2001). Chin et al. (2014) similarly shows a decrease in
parvalbumin in SOD1 G93A mice as well as a reduction in
sarcoplasmic/ER Calcium ATPase proteins, including SERCA1.
Notably, calcium binders, which fall under the calcium sink
category in this meta-analysis, show a slight dip that also
corresponds to the timing of the intracellular calcium increase
(Figure 2C).
Calcium release has a bi-directional relationship with ROS
production since ROS homeostasis is maintained via Ca2+
signaling and Ca2+ dependent pathways. Calcium stimulates
NO synthesis and leads to ROS production at Complex III
(Feissner et al., 2009). Moreover, because the ryanodine receptor
forms a tetramer with the sarcoplasmic and ERs, the reversible
oxidation of endogenous superoxide groups can result in the
release of additional calcium from the sarcoplasmic reticulum
(Fill and Copello, 2002). Finally, oxidative agents like peroxide
directly induce calcium release from the ER via IP3R (Wesson
and Elliott, 1995). In summary, free radicals induce calcium
leakage into the cytosol via the ryanodine receptor, Ca2+-
leak channels, and inositol 1,4,5-trisphosphate receptors, and
conversely, intracellular calcium concentration activates NOX
and NOS, which then produces additional excess ROS and
RNS, respectively (Chin et al., 2014). Ultimately, elevated
internal calcium creates a cyclical feed forward mechanism that
continually increases calcium and oxidative stress to the point of
apoptosis (Chin et al., 2014).
Lower respiration rates, and consequently, lower intracellular
ATP concentrations, directly contribute to the lowering of the
mitochondrial potential, which can ultimately initiate apoptotic
cascades. The impact of lower ATP concentration on oxidative
and calcium imbalances is bi-directional, with increases in
oxidants and calcium-mediated calcium release further impairing
mitochondrial function, especially Complex 1, a key constituent
for ATP production (Cassina et al., 2008; Cozzolino and Carri,
2012; Lautenschlager et al., 2013). Through a less direct path,
an increase in oxidative stress can also lead to a swelling
of mitochondria, which also further inhibits ATP production
(Martin et al., 2007). Finally, lower concentrations of ATP impede
calcium-ATPase in removing free calcium from the cytosol or
shuttling calcium back to the ER for storage (Kaplan et al., 2003;
Fuchs et al., 2013).
Deciphering the Timing: Cause, Effect, and
Instability
Because of their large size and innate emergent properties,
motoneurons are susceptible to homeostatic instabilities. It
has been previously shown that motoneurons, even in a
physiological state, have insuﬃcient mitochondrial capacity to
buﬀer large calcium ﬂuxes. Calcium buﬀering insuﬃciency is
thought to be due to a reduced mitochondrial density per
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volume compared to non-motoneurons (Grosskreutz et al.,
2007). Therefore, mitochondrial dysfunction and impaired
calcium homeostasis is hypothesized to account for the selective
vulnerability of motoneurons (Jaiswal and Keller, 2009; Jaiswal
et al., 2009). Another contributor for the selective vulnerability
of motoneruons is the requirement for axonal transport of
mitochondria over very long distances, up to 1 m (Mitchell and
Lee, 2009, 2012a; Lee and Mitchell, 2015). Finally, the dynamics
of somatic input processing of motoneurons could explain the
earlier death of fast twitch ﬁbers in ALS (Mitchell and Lee,
2011).
Because there are so many interacting variables, it is diﬃcult
to determine which parameter(s) initiate versus simply aﬀect
the pathophysiological cyclical cascades of depressed cellular
respiration, imbalances in calcium homeostasis, and intracellular
elevation of oxidants in ALS. The presented data reveals that
elevated oxidants appear later in the SOD1 G93A life span,
closer to disease onset. However, both calcium and cellular
respiration/mitochondrial mechanisms show early deﬁcits. Much
like the age-old question, “What came ﬁrst, the chicken or the
egg?” This meta-analysis begs the question, “What comes ﬁrst—
improper calcium homeostasis or depressed cellular respiration?”
Scientiﬁcally justiﬁed arguments could be made for either
position. Increased calcium permeability or ATP depletion from
sub-par cellular respiration, or a combination of both, could
initiate a dynamic instability in themotoneuron that results in the
ALS phenotype. The trend lines presented in this meta-analysis
reveal the presence of potential compensatory mechanisms,
which attempt but ultimately fail, to re-stabilize to homeostasis.
For example, between 0 and 20 days, there is a rise in HSPs and
a gradual increase in calcium sensitivity. The “slight bump” in
mitochondrial mechanisms/cellular respiration at pre-onset also
coincides with the lowest intracellular calcium levels. Attempts
to re-stabilize to homeostasis could potentially correspond to
the small ﬂuctuations apparent in Figures 1 and 2, although
more data is needed to deﬁnitively determine their statistical
signiﬁcance.
Mathematical instabilities within pathophysiological feedback
loops have already been identiﬁed in a dynamic meta-analysis
of the SOD1 G93A mouse model (Mitchell and Lee, 2012b). If
unstable pathology dynamics are the actual underlying culprit,
it may not actually matter exactly which mechanism ﬁrst
initiated the cascade (see Future Directions). Both preclinical
and clinical failures to obtain meaningful success using single-
mechanism treatments illustrate the potential validity of this
point. Among the many examples are: dichloroacetate (Miquel
et al., 2012), which attempts at restoring the mitochondrial
respiratory capacity in the astrocytes, N-acetyl-glucagon-like
peptide-1 (Sun et al., 2013), which endogenously regulates
metabolism by promoting insulin synthesis and secretion, and
creatine (Groeneveld et al., 2003; Snow et al., 2003; Beal, 2011),
which is known to enhance ATP synthesis. However, no single
treatment to targeting cellular energetics has been eﬀective
enough to translate to an eﬀective treatment for humans (Tadic
et al., 2014).
In this meta-analysis, we reveal that, although there are some
small ﬂuctuations, cellular respiration is depressed for the entire
SOD1 G93A ALS mouse lifespan. Interestingly, ALS patients,
prior to the onset of their ALS, have been found to be healthier
(e.g., less antecedent disease) than age, gender, and geography-
matched control subjects (Mitchell et al., 2015). However, such
patients could still have asymptomatic pre-ALS variations in
their underlying motoneuron regulation, which make them
more susceptible to instabilities. Hypervigilant regulation as
been put forth as one possibility to explain how the above-
average pre-ALS health of patients could be correlated to a
later, destabilizing motoneuron perturbation, which initiates ALS
(Mitchell et al., 2015). “Hypervigilant regulation” results when
underlying regulatory processes aggressively overreact to correct
imbalances from homeostasis, making them ‘hypervigilant’ to
perturbation (in control theory, referred to as a too-high feedback
gain). While hypervigilant regulation would initially be overall
protective, it could also result in greater later susceptibility
to destabilization, especially in highly susceptible motoneurons
(Mitchell et al., 2015). The temporal calcium, oxidant, and HSP
ﬂuctuations identiﬁed in this study, in combination with the
oscillatory behavior of other previously identiﬁed parameters
(Mitchell and Lee, 2012b) such as axonal transport (Mitchell and
Lee, 2012a) and excitability (Delestree et al., 2014), are suggestive
of the possible role of regulatory and homeostatic impairments as
being the “cause” of ALS.
Future Directions
Perhaps instead of focusing on mechanistic initiation, treatments
should focus on treating the underlying instability, itself (Mitchell
and Lee, 2008, 2012b). Whether in engineering process or in
biology, treating instability typically requires impacting multiple
targets or feedback loops, which may or may not have directly
initiated the destabilizing perturbation or event. Combination
treatments can leverage synergistic interactions to increase
treatment eﬀect size. Multiple experimentalists have attempted
combinatory treatments on the SOD1 G93A mouse model
(Waibel et al., 2004; Feng et al., 2008; Del Signore et al.,
2009; Del Barco et al., 2011). For example, Waibel et al.
(2004) experimented with rasagiline, an anti-apoptotic with
neuroprotective properties, combined with riluzole, a sodium
channel blocker, to reduce excitotoxicity. The combinatory
treatment did exhibit a statistically signiﬁcant improvement
compared to control and compared to Riluzole alone.
In addition to exploiting synergistic interactions to increase
eﬀect size, combination treatments could potentially be used
to re-stabilize the system to homeostasis. Theoretical SOD1
G93A ALS models of combination treatments have shown
this exciting possibility (Mitchell and Lee, 2012b). In fact,
of the several thousand computationally assessed combination
treatment permutations, a few percent of 2 and 3-way
treatment strategies were able to mathematically stabilize the
ALS pathophysiology (Mitchell and Lee, 2012b). Interestingly,
energetics was one of the pathophysiological categories that
most frequently appeared in synergistic or stabilizing treatment
combinations. Given the early and lasting depression of ATP
and respiration rates identiﬁed in the present study, it is not
surprising that energetics was previously predicted to have the
greatest single-category eﬀect size (Mitchell and Lee, 2012b).
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Based on the results of the present study, it would appear
that therapeutics leveraging the strong interactions within
the calcium-respiration-oxidation triad could be promising.
As shown in Figures 1 and 2, prior to onset, it appears
the SOD1 G93A physiology temporarily compensates toward
decreasing intracellular calcium, increasing anti-oxidative HSPs,
and slightly increasing respiration rate; thus, treatment to amplify
these existing compensatory mechanisms would seem intuitive.
However, like spinal cord injury (Mitchell and Lee, 2008),
such treatments would likely have to be initiated very early
in the disease process to have a meaningful eﬀect. In fact, in
the case of instability, the timing of treatment may be the
most important parameter, especially given human patients will
not be treated until after ALS symptoms appear. Obtaining
a ﬁner point on the timing and statistical signiﬁcance of
ﬂuctuations in intracellular calcium, ATP concentration, and
free radicals, is critical to devising combination treatments
that have clinically signiﬁcant results. An additional essential
research path is better assessment of homeostatic regulation.
Modulation of regulatory pathways may prove more fruitful for
re-stabilization than direct physical or chemical manipulation of
cellular elements.
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